InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,306.04
(
0.02%
)
US TECH 100
18,390.42
(
0.40%
)
Dow Jones
38,852.86
(
-0.55%
)
Brent Oil
84.35
(
1.81%
)
Bitcoin
68,458.37
(
-1.35%
)
Post# of 2340022
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jedijazz

Send PM Follow Ignore
Followers 1323
Posts 247940
Boards Moderated 61
Alias Born 12/07/2009

jedijazz

Member Level

Re: None

Monday, 05/06/2024 3:47:45 PM

Monday, May 06, 2024 3:47:45 PM

Post# of 2340022
$NRXP Based on the announcement today of its safety finding, NRx plans to seek Accelerated Approval of NRX-101 for treatment of bipolar depression in patients at risk for akathisia who are at highest risk of suicide. https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-announces-final-clinical-trial-results-superior-safety-combined-with-similar-efficacy-in-the-trial-of-nrx-101-compared-to-lurasidone-in-suicidal-bipolar-depression-302136430.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up